Kaposi's Sarcoma after Kidney Transplantation: a 21-Years Experience.

PubWeight™: 0.94‹?›

🔗 View Article (PMC 3915423)

Published in Int J Hematol Oncol Stem Cell Res on January 01, 2013

Authors

Dariyush Raeisi1, Mehrdad Payandeh2, Seyed Hamid Madani3, Mohammad Erfan Zare4, Atefeh Nasir Kansestani2, Amir Hossein Hashemian5

Author Affiliations

1: Department of nephrology, Kermanshah University of Medical Science, Kermanshah, Iran.
2: Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
3: Department of Pathology, Kermanshah University of Medical Science, Kermanshah, Iran.
4: Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran ; Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
5: Research Center for Environmental Determinants of Health (RCEDH), Kermanshah University of Medical Sciences, Kermanshah, Iran ; Department of Biostatistics and Epidemiology, Kermanshah University of Medical Sciences, School of Public Health, Kermanshah, Iran.

Articles cited by this

Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med (2005) 7.83

Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61

Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest (1997) 2.10

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75

Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41

In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS (1997) 1.40

Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies. Am J Clin Dermatol (2006) 1.31

Kaposi's sarcoma: the most common tumor after renal transplantation in Saudi Arabia. Am J Med (1988) 1.29

Antiviral drug susceptibility of human herpesvirus 8. Antimicrob Agents Chemother (1997) 1.23

Kaposi's sarcoma in transplant recipients. Transplantation (1997) 1.05

Kaposi's sarcoma risk among transplant recipients in the United States (1993-2003). Int J Cancer (2006) 1.02

Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect (2001) 1.00

Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution. Transplant Proc (1993) 1.00

Kaposi's sarcoma: a reversible hyperplasia. Lancet (1986) 0.98

Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.96

Successful treatment of post-transplant Kaposi's sarcoma by reduction of immunosuppression. Nephrol Dial Transplant (2002) 0.95

Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol (2001) 0.95

Clinical features and course of Kaposi's sarcoma in kidney transplant patients: report of 13 cases. Am J Nephrol (1994) 0.93

Development of malignancy following living donor kidney transplantation. Transplant Proc (2005) 0.86

HHV8 in renal transplant recipients. Transpl Int (2000) 0.83

Kaposi's Sarcoma and Transplantation. Herpes (2000) 0.82

Kaposi's sarcoma. Ann Transplant (1998) 0.82

Incidence of postrenal transplantation malignancies: a report of two centers in Tehran, Iran. Transplant Proc (2001) 0.81

Malignant tumors after renal transplantation. Artif Organs (2002) 0.80

Detection and subtyping of human herpesvirus-8 in renal transplant patients before and after remission of Kaposi's sarcoma. Transplantation (1998) 0.79

Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single center. J Nephrol (2003) 0.77

Kaposi's sarcoma: a natural model of interrelationships between viruses, immunologic responses, genetics, and oncogenesis. Antibiot Chemother (1971) (1983) 0.77